Target intelligence / Profile preview

Immunoglobulin kappa variable 1-5 (IGKV1-5)

Target
IGKV1-5
Molecular classification
Immunoglobulin variable region
01

Overview

Immunoglobulin kappa variable 1-5 (IGKV1-5) is a protein coding gene representing the variable (V) region of the kappa light chain of human immunoglobulins (antibodies)[1][2]. The V region of an immunoglobulin light chain, along with the V region of a heavy chain, forms the antigen-binding site of the antibody and is critical for the immense diversity of the immune response[1][2]. This region is assembled via V-(D)-J gene rearrangement and can be further diversified by somatic hypermutation, enabling adaptation to a wide array of antigens[2]. IGKV1-5 itself is not considered a direct therapeutic target, but is part of the larger structure of immunoglobulins which serve as the molecular basis for both natural and therapeutic antibody function. IGKV1-5 is detected in various tissues and body fluids as part of antibodies and its expression profile can be measured in health and disease, including cancer, where it may serve as a diagnostic or prognostic biomarker[4].

Other names
IGKVIGKV15Ig kappa chain V-I region CARIg kappa chain V-I region EUIg kappa chain V-I region HK102Ig kappa chain V-I region KueL12L12aV1Ig kappa chain V-region
02

Biological functions

Antigen bindingImmune response
03

Disease associations

CancerInfectionOther (generic immune function)
04

Biomarkers

Potential biomarker in cancer prognostics/tissue staining (cancer tissue expression data available, some associations with prognosis)

Beyond the preview

Go deeper on Immunoglobulin kappa variable 1-5 (IGKV1-5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 1-5 (IGKV1-5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call